Much of the research within the Drug Delivery group is focused on the analysis of human-associated microbes. The aim of this work is to better characterise these microbes in both health and disease.
The focus is to move from characterisation of what microbes are present, to develop a better understanding of the function of these microbes. From this improved understanding, similar improvements may follow in the longer term in terms of the treatment of infection.